Literature DB >> 27957047

Atrial Fibrillation in Athletes: The Role of Exercise.

Mohit K Turagam Md1, Poonam Velagapudi Md2, Abraham G Kocheril Md3.   

Abstract

There is growing evidence that atrial fibrillation (AF) is prevalent in athletes and even in individuals participating in intense long term exercise at a non-competitive level. Several causes have been described for these phenomena including atrial remodeling, atrial fibrosis, inflammation, autonomic activation, body fluid changes and changes in blood volume and pressure. This article reviews the epidemiology, pathophysiological mechanisms and management options of AF in regards to exercise.

Entities:  

Keywords:  Athletes; Atrial Fibrillation; Endurance Sports; Lone Atrial Fibrillation

Year:  2014        PMID： 27957047      PMCID： PMC4956135          DOI： 10.4022/jafib.1004

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  44 in total

1.  Work related physical activity and risk of a hospital discharge diagnosis of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Authors:  L Frost; P Frost; P Vestergaard
Journal:  Occup Environ Med       Date:  2005-01       Impact factor: 4.402

2.  Sport practice and the risk of lone atrial fibrillation: a case-control study.

Authors:  Roberto Elosua; Andreu Arquer; Lluís Mont; Antonia Sambola; Lluís Molina; Emilio García-Morán; Josep Brugada; Jaume Marrugat
Journal:  Int J Cardiol       Date:  2005-06-16       Impact factor: 4.164

3.  Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers.

Authors:  Hein Heidbüchel; Nicole Panhuyzen-Goedkoop; Domenico Corrado; Ellen Hoffmann; Allessandro Biffi; Pietro Delise; Carina Blomstrom-Lundqvist; Luc Vanhees; Per Ivarhoff; Uwe Dorwarth; Antonio Pelliccia
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2006-08

4.  Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation.

Authors:  Pieter Koopman; Dieter Nuyens; Christophe Garweg; Andre La Gerche; Stijn De Buck; Lieve Van Casteren; Becker Alzand; Rik Willems; Hein Heidbuchel
Journal:  Europace       Date:  2011-06-05       Impact factor: 5.214

5.  Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism.

Authors:  Don R Swanson
Journal:  Med Hypotheses       Date:  2006-02-28       Impact factor: 1.538

6.  Left atrial volume index in highly trained athletes.

Authors:  Antonello D'Andrea; Lucia Riegler; Rosangela Cocchia; Raffaella Scarafile; Gemma Salerno; Rita Gravino; Enrica Golia; Olga Vriz; Rodolfo Citro; Giuseppe Limongelli; Paolo Calabrò; Giovanni Di Salvo; Pio Caso; Maria Giovanna Russo; Eduardo Bossone; Raffaele Calabrò
Journal:  Am Heart J       Date:  2010-06       Impact factor: 4.749

7.  Biochemical evidence of myocardial fibrosis in veteran endurance athletes.

Authors:  M Mitchell Lindsay; Francis G Dunn
Journal:  Br J Sports Med       Date:  2007-02-20       Impact factor: 13.800

8.  Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists.

Authors:  Sylvette Baldesberger; Urs Bauersfeld; Reto Candinas; Burkhardt Seifert; Michel Zuber; Manfred Ritter; Rolf Jenni; Erwin Oechslin; Pia Luthi; Christop Scharf; Bernhard Marti; Christine H Attenhofer Jost
Journal:  Eur Heart J       Date:  2007-12-07       Impact factor: 29.983

Review 9.  Atrial fibrillation in endurance-trained athletes.

Authors:  A V Sorokin; C G S Araujo; S Zweibel; P D Thompson
Journal:  Br J Sports Med       Date:  2009-07-13       Impact factor: 13.800

10.  Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes.

Authors:  Naiara Calvo; Lluís Mont; David Tamborero; Antonio Berruezo; Graziana Viola; Eduard Guasch; Mercè Nadal; David Andreu; Barbara Vidal; Marta Sitges; Josep Brugada
Journal:  Europace       Date:  2010-01       Impact factor: 5.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.